The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2016
Filed:
Mar. 14, 2013
Applicant:
Liposcience, Inc., Raleigh, NC (US);
Inventors:
James D. Otvos, Cary, NC (US);
Irina Y. Shalaurova, Cary, NC (US);
Dennis W. Bennett, Shorewood, WI (US);
Justyna E. Wolak-Dinsmore, Durham, NC (US);
Thomas M. O'Connell, Chapel Hill, NC (US);
Kelly Mercier, Durham, NC (US);
Assignee:
LIPOSCIENCE, INC., Raleigh, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/50 (2006.01); G06F 19/00 (2011.01); G01R 33/46 (2006.01); G06F 17/10 (2006.01); G01N 24/08 (2006.01); G01R 33/465 (2006.01); A61B 5/00 (2006.01); A61B 5/055 (2006.01);
U.S. Cl.
CPC ...
G06F 19/3431 (2013.01); A61B 5/4842 (2013.01); A61B 5/7275 (2013.01); G01N 24/08 (2013.01); G01R 33/46 (2013.01); G01R 33/465 (2013.01); G06F 17/10 (2013.01); G06F 19/34 (2013.01); G06F 19/3437 (2013.01); A61B 5/055 (2013.01);
Abstract
Methods, systems and circuits evaluate a subject's risk of developing type 2 diabetes or developing or having prediabetes using at least one defined mathematical model of risk of progression that can stratify risk for patients having the same glucose measurement. The model may include NMR derived measurements of GlycA and a plurality of selected lipoprotein components of at least one biosample of the subject.